Mindera Health Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 34

Employees

  • Latest Deal Type
  • Series A3

  • Latest Deal Amount
  • $20.3M

  • Investors
  • 8

Mindera Health General Information

Description

Developer of molecular testing technology designed to be used for skin diseases and conditions. The company's technology specializes in developing and commercializing non-invasive, high-precision genomic tools for skin diseases by using a dermal biomarker patch, enabling healthcare institutions and patients to access pain-free, minimally invasive and targeted extraction of mRNA from the skin, without requiring a skin biopsy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Diagnostic Equipment
Corporate Office
  • 5795 Kearny Villa Road
  • San Diego, CA 92123
  • United States
+1 (858) 000-0000

Mindera Health Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mindera Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A3) 12-Dec-2022 $20.3M 0000 000.00 Completed Generating Revenue
4. Later Stage VC (Series A2) 11-May-2021 000.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series A) 14-Nov-2019 00.000 00.000 000.00 Completed Generating Revenue
2. Seed Round 12-Oct-2015 $1M $1M 00.00 Completed Generating Revenue
1. Accelerator/Incubator 01-Jun-2015 Completed Generating Revenue
To view Mindera Health’s complete valuation and funding history, request access »

Mindera Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A3 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A1 17,637,932 $0.000010 8% $0.33 $0.33 1x $0.33 20.67%
Seed 6,212,875 $0.000010 $0.22 $0.22 1x $0.22 7.28%
To view Mindera Health’s complete cap table history, request access »

Mindera Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of molecular testing technology designed to be used for skin diseases and conditions. The company's technology
Other Healthcare Technology Systems
San Diego, CA
34 As of 2024
0000
000.00 0000-00-00
00000000000 0000

000000

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incidid
0000000000 000000000
Austin, TX
000 As of 0000
000.00
00000 0000-00-00
000000&0 000.00

000000

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco la
0000000000 000000000
Irvine, CA
000 As of 0000
00000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mindera Health Competitors (32)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Asuragen Formerly VC-backed Austin, TX 000 000.00 000000&0 000.00
Agendia Venture Capital-Backed Irvine, CA 000 00000 00000000
Mobidiag Formerly PE-Backed Espoo, Finland 000 000.00 000000&0 000.00
Novigenix Venture Capital-Backed Epalinges, Switzerland 00 0000 00000000000 0000
Akonni Biosystems Venture Capital-Backed Frederick, MD 00 0000 0000000000 0000
You’re viewing 5 of 32 competitors. Get the full list »

Mindera Health Patents

Mindera Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021385427-A1 Microneedle devices and methods, and skin condition assays Pending 30-Nov-2020 00000000000
EP-4240238-A1 Microneedle devices and methods, and skin condition assays Pending 30-Nov-2020 00000000000
CA-3199737-A1 Microneedle devices and methods, and skin condition assays Pending 30-Nov-2020 00000000000
US-20230383352-A1 Microneedle devices and methods, and skin condition assays Pending 30-Nov-2020 0000000000 0
EP-4240238-A4 Microneedle devices and methods, and skin condition assays Pending 30-Nov-2020 A61B10/0045 0
To view Mindera Health’s complete patent history, request access »

Mindera Health Executive Team (9)

Name Title Board Seat Contact Info
Linh Le Chief Financial Officer & Chief Operating Officer
Tobin Dickerson Ph.D Co-Founder & Chief Scientific Officer
Fortunato Rocca Chief Executive Officer & President
Tahir Mahmood Ph.D Co-Founder & Board Member
You’re viewing 4 of 9 executive team members. Get the full list »

Mindera Health Board Members (9)

Name Representing Role Since
Andrew Offer Scientific Health Development Board Member 000 0000
Deborah Rice-Johnson Mindera Health Board Member 000 0000
Joseph Cook III Mountain Group Partners Board Member 000 0000
Joseph Cook Jr. Mountain Group Partners Board Member 000 0000
Samuel Bartholomew Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Mindera Health Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mindera Health Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Rockmont Partners Venture Capital Minority 000 0000 000000 0
Grant Park Ventures Venture Capital Minority 000 0000 000000 0
Primer Capital Venture Capital Minority 000 0000 000000 0
Bank Saint Petersburg Corporation Minority 000 0000 000000 0
MIT Alumni Angels of Northern California Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Mindera Health FAQs

  • When was Mindera Health founded?

    Mindera Health was founded in 2013.

  • Who is the founder of Mindera Health?

    Tobin Dickerson Ph.D, Philippe Nore, and Tahir Mahmood Ph.D are the founders of Mindera Health.

  • Who is the CEO of Mindera Health?

    Fortunato Rocca is the CEO of Mindera Health.

  • Where is Mindera Health headquartered?

    Mindera Health is headquartered in San Diego, CA.

  • What is the size of Mindera Health?

    Mindera Health has 34 total employees.

  • What industry is Mindera Health in?

    Mindera Health’s primary industry is Other Healthcare Technology Systems.

  • Is Mindera Health a private or public company?

    Mindera Health is a Private company.

  • What is the current valuation of Mindera Health?

    The current valuation of Mindera Health is 000.00.

  • What is Mindera Health’s current revenue?

    The current revenue for Mindera Health is 000000.

  • How much funding has Mindera Health raised over time?

    Mindera Health has raised $38M.

  • Who are Mindera Health’s investors?

    Rockmont Partners, Grant Park Ventures, Primer Capital, Bank Saint Petersburg, and MIT Alumni Angels of Northern California are 5 of 8 investors who have invested in Mindera Health.

  • Who are Mindera Health’s competitors?

    Asuragen, Agendia, Mobidiag, Novigenix, and Akonni Biosystems are some of the 32 competitors of Mindera Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »